| Financial Year |
March 31 2023 |
| Monetary Funds |
4,233,024,082.73 |
| Held-for-trading Financial Assets |
1,140,920.00 |
| Notes Receivable |
247,181,936.17 |
| Accounts Receivable |
5,790,683,457.54 |
| Advances to Suppliers |
2,231,654,164.29 |
| Other Receivables |
302,139,874.56 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
7,837,392,719.35 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
632,213,669.96 |
| Total Current Assets |
21,382,887,765.49 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,408,890,661.21 |
| Investment Properties |
-- |
| Fixed Assetes |
12,944,134,807.73 |
| Under-construction Projects |
4,670,831,808.90 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,135,369,395.51 |
| R&D expenses |
66,884,920.29 |
| Goodwill |
82,707,747.36 |
| Long-Term Deferred and Prepaid Expenses |
77,888,219.33 |
| Deferred Income Tax Assets |
177,670,088.67 |
| Other Non-Current Assets |
512,159,061.81 |
| Sub-Total of Non-Current Assets |
22,593,128,257.47 |
| Total Assets |
43,976,016,022.96 |
| Short-Term Loans |
4,496,707,341.07 |
| Trading Financial liabilities |
6,634,291.82 |
| Notes Payable |
2,128,435,327.42 |
| Accounts Payable |
805,634,594.16 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
79,260,342.12 |
| Taxes Payable |
139,598,616.94 |
| Interest Payable |
-- |
| Dividend Payable |
500,000.00 |
| Other payables |
2,556,017,357.09 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,121,960,939.35 |
| Other Current Liabilities |
250,922,222.85 |
| Sub-Total of Current Liabilities |
13,718,388,452.44 |
| Long-term Loans |
8,632,774,852.41 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
230,959,401.12 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
52,833,280.63 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
9,232,958,071.57 |
| Total Liabilities |
22,951,346,524.01 |
| Paid-In Capital(Or Share Stock) |
5,135,586,557.00 |
| Capital Surplus |
8,232,180,255.21 |
| Surplus Reserve |
117,421,380.75 |
| LESS:Treasury Stock |
153,065,091.30 |
| Undistributed Profits |
5,182,886,685.11 |
| Minority Stockholder's Interest |
2,462,932,413.95 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
18,561,737,085.00 |
| Owner's Equity（Stockholder's Equity） |
21,024,669,498.95 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
43,976,016,022.96 |
